The Latest

Medical device and pharma news and information

Medical Device and Pharmaceutical News

The latest information of interest to regulated industry. Bookmark this page to have a quick review for

    • FDA enforcement news
    • Regulatory updates
    • Innovative products
    • Compliance information, and
    • Other industry headlines.

And do not forget to check our pages for consumer safety information and regulatory services.

FDA Approves Wilserdly for Advanced Breast Cancer

Genentech’s oral estrogen receptor antagonist significantly extends progression-free survival, accompanied by FDA authorization of a liquid biopsy companion diagnostic.On November 16, 2026, the U.S. Food and Drug Administration (FDA) approved giredestrant (Wilserdly,...

read more

FDA Pivots from Artificial Intelligence to Super Intelligence

A Regulatory Solution in Search of a ProblemFDA's implementation of a presidential terminology mandate raises questions about scientific accuracy, regulatory consistency, and the responsible use of limited public health resources.Beginning November 16, 2026, the U.S....

read more

Science, Politics, Special Interests, and FDA Independence

Former Insiders Challenge the Administration's Health AgendaFormer FDA Commissioner Marty Makary and former Kennedy adviser Calley Means allege that political and commercial pressures interfered with federal health priorities. Their accounts raise questions about...

read more

When Preventable Diseases Return

Diseases once brought under control through vaccination have returned with devastating consequences. Historical outbreaks in the former Soviet Union and Japan offer important lessons as the United States confronts its largest measles resurgence in decades.For...

read more

Intersurgical 22mm Smoothbore Breathing Tubes and Systems

FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may cause breathing tube connectors to separate during use, potentially interrupting ventilation and exposing patients to serious injury or death.The...

read more

FDA Early Alert: Teleflex/Arrow Guidewire

Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially causing serious injury or death. No serious injuries or deaths have been reported.The U.S. Food and Drug Administration (FDA) has issued an Early...

read more

Pimicotinib (Pimjetmi) for Tenosynovial Giant Cell Tumor

On November 10, 2026, the Food and Drug Administration approved pimicotinib (Pimjetmi, EMD Serono, Inc.), a kinase inhibitor, for adults with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection may cause worsening functional limitation or...

read more

The Wolverine Peptide Stack: What We Know

Promoted for faster healing and injury recovery, two experimental peptides are attracting growing consumer interest despite limited human clinical evidence and unresolved safety questions.The promise sounds almost too good to be true: faster recovery from injuries,...

read more

Hims & Hers Moves Into Selling Unapproved Peptides

Telehealth company's planned expansion illustrates how quickly commercial markets are responding to changes in federal oversight of experimental therapies.Hims & Hers Health plans to begin offering new wellness treatments in November, including an unapproved...

read more

FDA Investigates Cancer Risk with Zolgensma Gene Therapy

Postmarketing reports identify cases of tumor formation linked to gene therapy vector integration, prompting FDA to evaluate potential regulatory action.The U.S. Food and Drug Administration (FDA) is investigating a serious potential cancer risk associated with...

read more